Why the study?
Does TEVAR plus optimal medical treatment reduce mortality and disease progression in patients with stable type B aortic dissection?
Population
Patients with stable type B aortic dissection
Comparison
Thoracic endovascular aortic repair plus optimal… vs Optimal medical treatment alone
Design
RCT, previously randomized
Follow-up
5 years
Authors
Loading...
Supports elective TEVAR in stable type B aortic dissection; extends RCT evidence to 5-year aorta-specific survival and reduced progression.
Does TEVAR plus optimal medical treatment reduce mortality and disease progression in patients with stable type B aortic dissection?
In patients with stable type B aortic dissection, adding TEVAR to optimal medical therapy improves 5-year aorta-specific survival and delays disease progression.
Nienaber et al. (2013) studied this question.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: